T. Rowe Price Associates’s Parexel International Corp PRXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-331,439
| Closed | -$29.2M | – | 2678 |
|
|
2017
Q3 | $29.2M | Sell |
331,439
-36,210
| -10% | -$3.17M | 0.01% | 1053 |
|
|
2017
Q2 | $32M | Buy |
367,649
+9,044
| +3% | +$674K | 0.01% | 994 |
|
|
2017
Q1 | $22.6M | Buy |
358,605
+11,400
| +3% | +$754K | ﹤0.01% | 1109 |
|
|
2016
Q4 | $22.8M | Sell |
347,205
-10,155
| -3% | -$637K | ﹤0.01% | 1095 |
|
|
2016
Q3 | $24.8M | Buy |
357,360
+36,870
| +12% | +$2.49M | 0.01% | 1054 |
|
|
2016
Q2 | $20.2M | Sell |
320,490
-1,990
| -0.6% | -$123K | ﹤0.01% | 1099 |
|
|
2016
Q1 | $20.2M | Sell |
322,480
-5,040
| -2% | -$311K | ﹤0.01% | 1073 |
|
|
2015
Q4 | $22.3M | Buy |
327,520
+33,340
| +11% | +$2.17M | ﹤0.01% | 1047 |
|
|
2015
Q3 | $18.2M | Buy |
294,180
+12,673
| +5% | +$852K | ﹤0.01% | 1121 |
|
|
2015
Q2 | $18.1M | Buy |
281,507
+19,500
| +7% | +$1.31M | ﹤0.01% | 1166 |
|
|
2015
Q1 | $18.1M | Buy |
262,007
+20,400
| +8% | +$1.3M | ﹤0.01% | 1166 |
|
|
2014
Q4 | $13.4M | Buy |
241,607
+24,527
| +11% | +$1.41M | ﹤0.01% | 1243 |
|
|
2014
Q3 | $13.7M | Sell |
217,080
-3,300
| -1% | -$188K | ﹤0.01% | 1221 |
|
|
2014
Q2 | $11.6M | Buy |
220,380
+12,700
| +6% | +$637K | ﹤0.01% | 1282 |
|
|
2014
Q1 | $11.2M | Sell |
207,680
-2,800
| -1% | -$143K | ﹤0.01% | 1269 |
|
|
2013
Q4 | $9.51M | Buy |
210,480
+1,500
| +0.7% | +$68.6K | ﹤0.01% | 1297 |
|
|
2013
Q3 | $10.5M | Buy |
208,980
+15,500
| +8% | +$759K | ﹤0.01% | 1260 |
|
|
2013
Q2 | $8.89M | Buy |
+193,480
| New | +$8.5M | ﹤0.01% | 1284 |
|
Other funds holding PRXL
T. Rowe Price Associates's PRXL Position: Q4 2017 in Review
T. Rowe Price Associates sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 331,439 shares — an estimated $29.2M sold.
T. Rowe Price Associates first reported a position in PRXL in Q2 2013 and held it in 18 quarters. The position peaked at $32M in Q2 2017. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.
- T. Rowe Price Associates reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
- T. Rowe Price Associates sold 331,439 Parexel International Corp shares in Q4 2017, an estimated $29.2M.
- T. Rowe Price Associates first reported a position in Parexel International Corp in Q2 2013 and held it in 18 quarters.
- T. Rowe Price Associates's Parexel International Corp position peaked at $32M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.